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D-Dimer as an Independent Predictor for Poor Outcome
After Aneurysmal Subarachnoid Hemorrhage
Seppo Juvela, MD, PhD; Jari Siironen, MD, PhD
Background and Purpose—After aneurysmal subarachnoid hemorrhage (SAH), elevated D-dimer levels have been
associated with poor clinical condition and outcome. We tested prospectively whether D-dimer values affect outcome
after SAH independently of severity of bleeding.
Methods—Previous diseases, and clinical as well as radiological variables, were recorded for 136 patients with SAH
admitted within 48 hours after bleeding. Plasma D-dimer was measured in the morning after aneurysm occlusion and at
discharge 10 to 12 days after SAH. Factors predicting poor outcome according to the Glasgow Outcome Scale at 3
months after SAH and appearance of cerebral infarction were tested with multiple logistic regression.
Results—Patients with poor outcome had higher D-dimer values than did those with favorable outcome: after surgery, a
median 1250 (25th and 75th percentiles 675 and 2900) g/L versus 720 (350 and 1119) g/L (P0.001); and at
discharge, 1150 (624 and 2875) g/L versus 360 (330 and 600) g/L (P0.001), respectively. In repeated-measures
ANOVA, D-dimer decreased more rapidly (P0.022) in those with favorable outcome. After simultaneous adjustment
for several factors affecting outcome, plasma D-dimer after surgery remained a significant predictor for poor outcome
(odds ratio, 1.63 per mg/L; 95% CI, 1.03 to 2.60; P0.038) but neither for delayed ischemia nor, on follow-up computed
tomography in survivors, for cerebral infarction.
Conclusions—Elevated plasma D-dimer after admission independently predicts poor outcome, suggesting that prolonged
excess thrombin generation may impair outcome. Repeated high plasma D-dimer values can be useful in discovering
patients at increased risk for poor outcome. (Stroke. 2006;37:1451-1456.)
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Aneurysmal subarachnoid hemorrhage (SAH) is a se-rious disease with high rates of case fatality (40%)
and morbidity.1,2 During aneurysm rupture, blood contacts
the extravascular matrix, leading to an activation of both
blood coagulation and fibrinolysis. After aneurysm rup-
ture, high levels of markers of thrombin generation (thrombin–
antithrombin complex and prothrombin fragments 12) and
particularly of the fibrin degradation product D-dimer (marker of
thrombin generation and cross-linked fibrin turnover) in plasma
correlate with poor clinical condition and outcome.3–6 Elevated
plasma D-dimer levels after SAH and surgery may also predict
delayed cerebral ischemia4 and cerebral infarction.5 However,
what has remained unclear is whether D-dimer, independently of
severity of bleeding as assessed with clinical and radiological
variables, is a risk factor for poor outcome.
We recently published the results of univariate associa-
tion of D-dimer with patients’ clinical condition and
outcome taking into account elapsed time after SAH.6
After that study, we continued to collect more patients to
improve power of the study. In this study, plasma D-dimer,
the most stable parameter of coagulation and fibrinoly-
sis,6,7 was obtained on the first postoperative day after
aneurysm surgery as well as at discharge from hospital to
investigate whether elevated levels, independent of known
risk factors, lead to increased risk for poor outcome and, in




This prospective study included 136 consecutive patients (69 men
and 67 women; 23.2 to 75.7 years of age; mean 50.2 years) with
aneurysmal SAH who were admitted to our hospital within 48 hours
after bleeding and whose aneurysms were occluded. After admission,
patients and family members were interviewed with a structured
questionnaire for previous diseases, medication, and health habits.
Of the 44 (32%) patients with a history of hypertension (pre-SAH
blood pressure readings 140/90 mm Hg or use of antihypertensive
medication), 10 (7%) had values 160/95 mm Hg. Two (1%)
patients had diabetes mellitus, 6 (4%) had coronary heart disease,
and 27 (20%) had used nonsteroidal anti-inflammatory drugs before
SAH.
Clinical Monitoring, Treatment, and Outcome
Each patient’s clinical condition on admission and during blood
sampling was scored according to the World Federation of
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Neurological Societies (WFNS) Grading Scale.8 All ruptured
aneurysms were occluded within a mean 24 hours after bleeding
(median 22; range 5 to 60 hours) by open surgery. During surgery,
39 (29%) patients underwent temporary occlusion of the proximal
artery (mean 7.6 and median 5.0 minutes; in 9 patients, 10
minutes). Bolus administration of thiopental (5 to 10 mg/kg) and
elevation of mean blood pressure were used routinely before
temporary artery occlusion. Mannitol use was routine in all
operations. Permanent artery occlusion was visible on angiogra-
phy in 5 (4%) patients: clipping of the aneurysm together with the
artery (in 3) or trapping or proximal clipping of a fusiform
aneurysm (in 2).
Nimodipine treatment was started after admission and continued until
21 days after SAH. No hypertensive, hypervolemic, nor endovascular
vasospasm therapy was routine but was used if ischemic symptoms
occurred. Patients who underwent surgery received betamethasone
routinely, 4 mg every 6 hours, starting before surgery and continuing
until the sixth postoperative day.
Neurological examinations took place daily after admission.
Delayed cerebral ischemia (reversible ischemic neurological deficit
and fixed ischemic neurological deficit) was determined as a gradual
development of focal neurological signs or deterioration in con-
sciousness (decrease of 1 point in motor response of Glasgow
Coma Scale)8 for no known reason, for example, intracerebral
hematoma (ICH), rebleed, hydrocephalus. Causes of poor clinical
condition were determined by repeated computed tomography (CT)
scanning, routine postoperative angiograms, autopsies, or laboratory
investigations.
CT scans were routinely performed on admission, on the first
postoperative day, at discharge, and at 3 months; scans were
repeated if clinical deterioration occurred. The amount of sub-
arachnoid blood on the CT scan at admission was categorized
according to Fisher et al.8 Seventeen patients (13%) showed
moderate to severe and 54 (40%) showed slight (small amount of
blood in occipital horns or in the third or fourth ventricle)
intraventricular hemorrhage (IVH).
Outcome was assessed at 3 months after SAH according to the
Glasgow Outcome Scale (GOS) and modified Rankin Scale.8 A
planned follow-up CT scan at 3 months after SAH was available
for 125 (92%) patients to reveal occurrence of permanent hypo-
dense areas consistent with cerebral infarction. Of the 11 cases
with a missing CT scan, 8 had died during follow-up.
The hypodense lesions, none of which were visible on the CT scan
at admission, appeared on follow-up scans of 80 (64%) patients.
Causes of lesions on CT were grouped as follows: group 1: lesion in
the same area as a previous ICH (n8 patients) or lesion attributable
to damage to a penetrating artery during surgery (n8), temporary or
permanent occlusion of the proximal artery of a saccular aneurysm
(n10) or other reasons (spatula pressure during surgery, angio-
graphic complication, or cardiovascular embolus; n12), or multiple
causes (n5); group 2: lesion assumed to result from delayed
cerebral ischemia after exclusion of other causes and appearing later
than on the first postoperative CT scan (n37 patients). On
follow-up CT scans of 56 patients, lesions were small (20 mm in
diameter).
D-Dimer Analysis
Both SAH4–6 and aneurysm surgery5,9 separately raise plasma
D-dimer levels. Postoperatively at 3 days after SAH, D-dimer levels
are highest and show a high correlation with outcome and delayed
cerebral ischemia.4–6 For this reason, our routine fasting blood
samples in the morning were collected twice: (1) within 12 to 24
hours after aneurysm occlusion (meanSD; 4213 hours; median
40 hours after SAH), and (2) at discharge 10.31.2 (median 11) days
after SAH.
Free-flowing blood was collected into polypropylene tubes
containing the anticoagulant and processed essentially as reported
previously.5 Sodium citrate (3.2%; 0.11 mol/L), at a ratio of 1
volume to 9 volumes of blood, served as the anticoagulant.
D-dimers were measured with a quantitative latex assay (Tina-
quant; Roche Diagnostics GmbH). According to the manufac-
turer, the intra-assay and interassay coefficients of variation have
been 8.3%.
Statistical Analysis
Data were analyzed with the SPSS for Windows (release 12.0.1.2003;
SPSS Inc). For univariate statistics, conventional statistical tests were
used. Association of continuous variables was tested by Spearman rank
(rs) correlation coefficients.
The effect of elapsed time after SAH and grouping variables on
D-dimer values (expressed as median with the 25th and 75th
percentiles or interquartile range) were compared by repeated-
measures ANOVA. For this analysis, values for D-dimer were
analyzed after logarithmic transformation to obtain the normal
distribution and equality of variances between different groups.
Odds ratios (ORs) and 95% CIs of risk factors, including their
interactions, for poor outcome and for ischemic lesions on the
follow-up CT scan were analyzed by unconditional logistic
regression. A 2-tailed P value 0.05 was considered significant.
Results
Plasma D-dimer values on the first postoperative day
(median 800 g/L; 25th to 75th percentile range; 380 to
1705 g/L; meanSD; 12651157 g/L) significantly
(rs0.577; P0.001) correlated with D-dimer values at dis-
charge (430; 340 to 800 g/L; 9311179 g/L). The decline
in D-dimer values with elapsed time after SAH was also
significant (P0.001). Elevated plasma D-dimer levels
(500 g/L) on the first postoperative day compared with
normal levels by baseline characteristics are shown in Table
1. Patients with elevated D-dimer levels were older and were
more likely to have used antihypertensive medication. Ciga-
rette smokers had lower D-dimer levels than did others
because current cigarette smokers were significantly
(P0.019) younger than noncurrent smokers (47.710.9
versus 53.214.3 years).
WFNS and IVH grades on admission, as well as outcome
scales, correlated with plasma D-dimer levels both after
surgery and particularly at discharge, when D-dimer also
correlated with occurrence of early rebleeding, Fisher grade,
and admission hyperglycemia (Table 2). D-dimer levels also
predicted later occurrence of a shunt-dependent hydrocephalus.
Poor-grade patients were quite frequently treated with ven-
triculostomy (17 patients) and later with a permanent shunt (9
patients) to improve cerebral perfusion pressure, although
ventricle size was not necessarily significantly increased.
Chronic shunt-dependent hydrocephalus was seen in 18 patients
(13%).
Plasma D-dimer levels after surgery did not predict
delayed cerebral ischemia, but at discharge, the levels were
higher (P0.038) in those with ischemia (632; 370 to 1456
g/L) than in those without ischemia (406; 350 to 700
g/L), although severity of symptoms was not signifi-
cantly associated with D-dimer levels (rs0.163;
P0.087). Occurrence of ischemic lesions on the CT scan
at 3 months did not associate with D-dimer levels after
surgery (753; 350 to 1581 g/L for those with a lesion and
1000; 370 to 1733 g/L for those without a lesion).
However, D-dimer levels were elevated (P0.05) at dis-
charge in those with an ischemic lesion compared with
those without (492; 350 to 944 versus 364; 330 to 637
g/L). The cause of the ischemic lesion did not seem to
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associate with D-dimer levels at discharge (Table 2), but
lesion size did (P0.040).
When, for each patient, only the most important cause of
poor outcome or clinical deterioration was taken into
account, D-dimer levels after surgery were significantly
(P0.007) associated only with severe initial bleeding
compared with those without any deterioration (900; 600
to 2686 g/L; n28 versus 563; 340 to 1000 g/L; n48).
Plasma D-dimer values did not associate significantly with
location of ruptured aneurysm, number of aneurysms
(rs0.105; P0.22), timing of surgery (rs0.043;
P0.62), or with duration (rs0.078; P0.37) or number
of episodes (rs0.083; P0.33) of temporary proximal
artery occlusion, permanent artery occlusion (P0.38), or
number of blood transfusion units (rs0.130; P0.13; data
not shown).
Plasma D-dimer values both on the first postoperative
day and at discharge were highly correlated with outcome
scales (Table 2). Particularly, those who had died or were
severely disabled according to GOS (poor outcome or
dependent state) at 3 months had significantly (P0.001)
higher D-dimer values both after surgery (1250; 675 to
2900 g/L) and at discharge (1150; 624 to 2875 g/L)
than did those with a favorable outcome (independent
state; 720; 350 to 1119 g/L; and 350; 330 to 600 g/L,
respectively). The decrease in D-dimer values with elapsed
time after SAH was also significant (P0.001), and it was more
prominent (for interaction between groups and elapsed time;
P0.022) in those in an independent state than in those with
poor outcome.
When D-dimer levels were tested according to GOS at 3
months (between factor: poor outcome versus independent
state), with covariates being IVH (no/yes) and WFNS both
on admission and during blood sampling (grade 1 versus
others), D-dimer levels still were significantly higher in
those with a poor outcome (P0.001). In this analysis, IVH
and WFNS as well as their interaction with elapsed time after
SAH had no noticeable effect on the significant association
between outcome and D-dimer levels. Interaction between out-
come and elapsed time had a significant (P0.028) effect on
D-dimer level.
Table 3 shows that several variables obtained soon after
admission predicted poor outcome in univariate analysis.
In multivariate analysis (model I), the significance of
Fisher grades, early rebleeding, and plasma glucose as
predictors decreased because these variables significantly
correlated with patient age and with occurrence of IVH or ICH.
Significant independent risk factors for poor outcome were best
predicted by patient age, occurrence of IVH or ICH, plasma
D-dimer after surgery, and almost significantly (P0.075) with
WFNS grade 1. After additional simultaneous adjustment for
gender, history of hypertension, occurrence of rebleeding, dura-
tion of temporary or permanent occlusion of the proximal artery
during surgery, and for amount of subarachnoid blood, plasma
D-dimer after surgery remained a significant predictor for a poor
outcome (OR, 1.63; 95% CI, 1.03 to 2.60 per mg/L; P0.038).
When the dichotomous WFNS variable was replaced by
a 3-category WFNS grade (I, II–III, and IV–V) in multi-
variate model I of Table 3, plasma D-dimer after surgery
remained a significant predictor for a poor outcome, OR
1.60 per mg/L (95% CI, 1.03 to 2.50; P0.038). After
adjustment for delayed cerebral ischemia, the significance
of D-dimer increased, suggesting that the association of
D-dimer with outcome was not attributable to symptomatic
vasospasm (Table 3; model II).
D-Dimer level after surgery was not a risk factor for
ischemic lesion on the follow-up CT (1.00; 0.72 to 1.39 per
mg/L) or for symptomatic delayed cerebral ischemia (1.03;
0.74 to 1.42 per mg/L). Significant independent risk
factors for ischemic lesions on the follow-up CT scan at 3
TABLE 1. Baseline Characteristics of 136 SAH Patients According to Plasma
D-Dimer Levels on the First Postoperative Day
Characteristic
D-Dimer Levels
Normal (n40) Elevated (n96) All Patients (n136)
Women (%) 19 (48) 48 (50) 67 (49)
Age (meanSD; y)* 45.411.1 52.213.0 50.212.8
Body mass index (meanSD) 25.53.2 25.44.1 25.43.8
Hypertension (%) 9 (23) 35 (36) 44 (32)
Antihypertensive medication (%) 2 (5) 16 (17) 18 (13)
Cigarette smoking (%)
Ever regular† 32 (80) 56 (59) 88 (65)
Current† 29 (73) 46 (48) 75 (55)
Heavy alcohol drinker (%) 4 (10) 7 (7) 11 (8)
Coronary disease (%) 1 (3) 5 (5) 6 (4)
Premonitory leak symptoms (%) 5 (13) 3 (3) 8 (6)
Use of aspirin before hemorrhage (%) 4 (10) 11 (11) 15 (11)
Normal D-dimer values 500 g/L; body mass index calculated as a measure of weight/height2;
kg/m2.
*P0.004 for difference between groups; †P0.05.
Juvela and Siironen D-Dimer After Aneurysmal Subarachnoid Hemorrhage 1453
months were WFNS grade 1 on admission (OR, 2.49;
95% CI, 1.03 to 6.04; P0.043), a thick layer or localized
subarachnoid clots on the initial CT scan (4.79; 1.95 to
11.80; P0.001), and history of hypertension (3.65; 1.35
to 9.88; P0.011).
Discussion
On the basis of this study, elevated plasma D-dimer values
after early surgery, and particularly if persisting for 1 to 2
weeks after SAH, independent of severity of bleeding and
several confounding factors predict poor outcome. Patients
with prolonged blood hypercoagulability seem to recover
less well than expected based on other prognostic factors.
On the other hand, D-dimer values do not independently
predict occurrence of delayed cerebral ischemia or perma-
nent ischemic lesions visible on CT scans.
Outcome after SAH is determined principally by severity
of initial bleeding.1,2 After SAH, the possibility of poor
outcome rises because of disease-associated (delayed ische-
mia, rebleeding, and hydrocephalus) and treatment-associated
(temporary or permanent proximal artery clipping, etc) fac-
tors.1,2,8,10 Aneurysm rupture frequently also causes stress
hyperglycemia, which, independent of severity of bleeding or
of metabolic syndrome, elevates risk for poor outcome.10
Outcome after SAH is thus probably determined by multiple
independent factors.
After SAH, endothelial injury and intimal platelet accu-
mulation are the earliest arterial wall changes.11 A sudden
rise in intracranial pressure, but neither subarachnoid
blood amount nor acute arterial hypertension, is responsi-
ble for the acute blood–arterial wall barrier disruption after
experimental SAH.12 Tissue factor may be released through
disrupted endothelium, leading to abrupt thrombin generation
and coagulation activation.3–6 Because elevated D-dimer, the
most stable parameter of coagulation and fibrinolysis,6,7 seems
to predict independently poor outcome after SAH, it is possible
that prolonged excess thrombin generation and cross-linked
fibrin turnover may impair cerebral circulation after aneurysm
rupture. Increased D-dimer levels may reflect ongoing thrombus
formation within cerebral vessels or may be a marker of
systemic hypercoagulability. D-dimer may also be only an
epiphenomenon of severe SAH. Among patients with brain
infarction, D-dimer level at hospital admission has been consid-
ered an independent risk factor for progressing ischemic stroke.7
In our patient population, D-dimer values after SAH
correlated with severity of bleeding, plasma glucose val-
ues, and patient age but not with body mass index or
history of hypertension. Thus, elevated D-dimer levels and
increased blood coagulability after SAH are likely attrib-
utable to severe aneurysm rupture itself and only in part
can be explained by stress reaction, surgery, or metabolic
syndrome. This aneurysm rupture–induced increase in
blood coagulability seems to be so marked that enoxaparin,
a low–molecular weight heparin at a dose of 40 mg once
daily for 10 days had no effect on outcome, occurrence of
post-SAH cerebral infarction, or D-dimer levels.6,8,13
However, D-dimer is not a specific marker of poor
outcome; surgery itself increases D-dimer levels.5,6,9 This
fact did not cause bias in our study because all patients
TABLE 2. Clinical and Radiological Variables Versus Plasma
D-Dimer Values for SAH Patients
Characteristic n
Plasma D-Dimer
After Surgery At Discharge
WFNS grade on admission*
I 75 709 (350–1100) 350 (330–600)
II–III 34 800 (389–1656) 378 (350–689)
IV–V 27 2000 (750–3300) 1400 (460–2447)
Rebleeding
None 127 800 (350–1700) 409 (350–716)
Present 9 1000 (556–3350) 1400 (700–3974)†
Fisher grade on admission
CT scan
Thin layer or diffuse deposition 37 711 (350–1476) 360 (340–600)
Thick layer or localized clots 99 831 (356–1706) 600 (350–1219)‡
ICH
None 119 831 (439–1700) 420 (350–739)
Present 17 400 (350–2271) 649 (360–1700)
IVH§
None 65 709 (350–1137) 350 (320–600)
Slight 54 941 (600–1702) 600 (340–1400)
Moderate or severe 17 1800 (431–3750) 800 (370–2447)
Plasma hyperglycemia at admission
No 32 800 (360–1156) 360 (348–596)
Yes 101 831 (370–1900) 600 (360–1400)†
Delayed cerebral ischemia
None 99 739 (360–1706) 406 (350–700)
RIND 13 1000 (778–2435) 541 (350–1747)
FIND 24 800 (600–1325) 700 (350–1456)
Shunt-dependent hydrocephalus
None 109 756 (350–1183) 359 (330–697)
Present 27 1400 (700–2217) 900 (524–2875)
GOS at 3 months#
Good recovery or minimal disability 78 710 (350–1119) 350 (300–600)
Moderate disability 20 740 (411–1466) 359 (330–680)
Severe disability or vegetative state 30 1250 (538–2925) 1150 (673–3025)
Death 8 1300 (725–2630) 1076 (350–2370)
Modified Rankin scale at
3 months**
No symptoms 23 700 (340–1100) 350 (320–600)
Minor symptoms 40 800 (381–1164) 350 (330–600)
Slight disability 26 719 (350–2008) 406 (340–989)
Moderate disability 28 1100 (625–2356) 716 (350–1725)
Moderately severe disability 8 525 (350–2448) 800 (350–5437)
Severe disability 3 3700 (2305–4850) 800 (646–2387)
Death 8 1300 (725–2630) 1076 (350–2370)
Hypodense areas on follow-up CT scan
None 45 1000 (370–1733) 364 (330–637)
Group 1 43 787 (360–1706) 488 (350–1132)
Group 2 37 700 (411–1100) 492 (360–900)
Values are expressed as medians with 25th to 75th percentile (interquartile) range
(g/L). Normal plasma glucose values are 4 to 6.4 mmol/L (72–115 mg/dL).
*For correlation between grades and D-dimer values after surgery rs0.276,
P0.001 and at discharge rs0.328, P0.001; †P0.01 between groups at
discharge; ‡P0.015 between groups at discharge; §rs0.202, P0.018 after
surgery and rs0.315, P0.001 at discharge; P0.019 for difference after surgery,
and P0.001 at discharge; #rs0.258, P0.002 after surgery and rs0.399,
P0.001 at discharge; **rs0.233, P0.006 after surgery and rs0.356, P0.001 at
discharge.
RIND indicates reversible ischemic neurological deficit; FIND, fixed ischemic neuro-
logical deficit.
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underwent surgery usually on an emergency basis and
because neither temporary nor permanent parent artery
clipping nor amount of blood transfusion units had any
significant effect on the association between D-dimer
values and poor outcome. Furthermore, we included in the
present study only postoperative samples. In our previous
article, the effect of microsurgery for ruptured aneurysm
on D-dimer levels was modest (increase from 12891812
g/L at admission to 14501308 g/L after surgery;
P0.067) when compared with the effect of SAH.6
D-Dimer levels are also elevated because of venous
thromboembolism, but we had only 3 cases with symptom-
atic deep venous thrombosis, of whom only 1 had symp-
toms during blood sampling at discharge. No pulmonary
emboli occurred within the first 2 weeks after SAH. Some
of the patients in poor clinical condition may have had
asymptomatic deep venous thrombosis, but this is unlikely
to have affected early-phase D-dimer levels. Furthermore,
clinical condition was taken into account in our statistical
analyses.
A reactant inflammatory process did not explain the
association between D-dimer levels and outcome. The first
samples were drawn during the early phase after SAH. For
the first patients, C-reactive protein, fibrinogen, and leu-
kocyte count were also analyzed simultaneously.6 In this
subset of patients, none of these acute-phase reactants but
only D-dimer was a nearly significant predictor for poor
outcome (univariate OR, 2.48; 95% CI, 0.96 to 6.38 per
mg/L; P0.060). In our previous SAH study, the acute-
phase reactants fibrinogen and C-reactive protein did not
correlate with coagulation activity or fibrinolysis except
for plasminogen activator inhibitor-1 activity.6 Further-
more, routine measurements of coagulation such as acti-
vated partial thromboplastin time and prothrombin time
failed to correlate with D-dimer or outcome.
In conclusion, we found that D-dimer, which can act as
a marker for fibrinolysis or hypercoagulability, indepen-
dent of severity of bleeding was associated with outcome.
However, this study could not show a causal relationship
between increased blood coagulability and poor outcome.
What also remains unknown is whether safer anticoagu-
lants than those available nowadays, or whether induced
hypertension, hemodilution, or hypervolemia started soon
after aneurysm rupture, can reduce blood coagulability and
thus improve cerebral blood circulation and outcome.
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